Conduit Pharmaceuticals logo

Conduit Pharmaceuticals (CDT) Q1 2026 Annual Earnings

CDT·Reported May 28, 2026·Before market open

Conduit Pharmaceuticals reported Q1 2026 revenue of $696.4M. Diluted EPS came in at $13.10.

Revenue
$696.4M
Diluted EPS
$13.10
SEC

SEC Filings

Earnings release8-K not filed yet
Annual report10-K · 0001493152-26-016858

Financial Snapshot

Trailing eight quarters through Q1 2026

View all metrics

Q1 2026 Earnings FAQ

Common questions about Conduit Pharmaceuticals's Q1 2026 earnings report.

Conduit Pharmaceuticals (CDT) reported Q1 2026 earnings on May 28, 2026 before market open.

Conduit Pharmaceuticals reported revenue of $696.4M and diluted EPS of $13.10 for Q1 2026.

You can read the 10-K periodic report (0001493152-26-016858) directly on SEC EDGAR. The filing index links above go to sec.gov.